Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
One in five female oncologists considering leaving academia, survey finds
“There are many indications that women are leaving medicine in disproportionately high numbers,” said Dr. Julie Silver.
News
Most cancer patients with breakthrough COVID-19 infection experience severe outcomes
Of 54 fully vaccinated patients with cancer and COVID-19, 65% were hospitalized and 13% died within 30 days.
News
High-fiber diet may improve melanoma immunotherapy response, outcomes
Previous research has suggested that the microbiome can influence patients’ response to immunotherapy.
News
Cardiovascular effects of breast cancer treatment vary based on weight, menopausal status
The risk of dyslipidemia was higher in postmenopausal aromatase inhibitors users and lower in postmenopausal tamoxifen users, compared with...
News
Ongoing HER2 breast cancer therapy may cost an additional $68,000 per patient
A Canadian study suggests that significant increases in cost per patient can be expected if funding policies don’t evolve to meet treatment needs...
News
Customizing pre-CAR T chemotherapy could improve ALL patient outcomes
Findings suggest a way to reduce relapses in patients undergoing CAR T-cell therapy: Tailor pre-CAR T lymphodepleting therapy.
News
FDA expands pembrolizumab approval for advanced melanoma
Approval was based on first interim findings from the randomized, placebo-controlled KEYNOTE-716 trial, which evaluated patients with stage IIB...
News
CLL and COVID-19: Outcome trends and lessons learned
Data highlight opportunities for further investigation into optimal management of COVID-19, immune response after infection, and effective...
News
Differences in response to immunotherapy in men versus women
It remains unclear whether the increased risk for death in women is a result of treatment side effects or lack of efficacy.
News
Easing access to DLBCL treatments: Patient study reveals racial differences
Collaborative follow-up models could improve access to cellular therapies, but more customized strategies are also needed.
News
Most oncology trainees encounter discrimination, don’t report it, survey finds
“I thought at some point [the racism and discrimination] would stop, but after all that training. . .I still had to prove myself.”
News
Cancer drug revenue increased 70% over a decade
“Cancer drugs now account for approximately 27% of new drug approvals in the United States, compared to 4% in the 1980s.”
News
Should you tell your doctor that you’re a doctor?
“I wouldn’t have treated him differently, but I just could have discussed the procedure with him in more professional terms.”
News
Data from Spain yield new insights on a rare hemophilia
Findings show high rates of antithrombotic use before diagnosis and fatal infections after immunosuppressive therapy starts.